8-K: Hinge Health Q3 2025: Revenue Soars 53%, Free Cash Flow Hits Record

Hinge Health reported strong third-quarter 2025 financial results, with revenue increasing 53% year-over-year and record free cash flow, driven by growth in clients and members.

Summary

• Revenue increased 53% year-over-year to $154.2 million in Q3 2025, compared to $100.6 million in Q3 2024.
• GAAP gross margin was 82% in Q3 2025, up from 79% in Q3 2024, while non-GAAP gross margin was 83%, also up from 79%.
• GAAP loss from operations was $6.1 million in Q3 2025, compared to a $3.9 million loss in Q3 2024.
• Non-GAAP income from operations was $30.4 million in Q3 2025, a significant improvement from a non-GAAP loss of $3.7 million in Q3 2024.
• Net cash provided by operating activities was $82.4 million in Q3 2025, up from $28.4 million in Q3 2024.
• Free cash flow reached a record $81.3 million in Q3 2025, compared to $27.5 million in Q3 2024.
• Cash, cash equivalents, marketable securities, and restricted cash totaled $496.9 million as of September 30, 2025.
• Last Twelve Months (LTM) calculated billings increased 50% to $624.2 million as of Q3 2025, from $416.9 million in Q3 2024.
• The number of clients grew 25% to 2,560, up from 2,047 in Q3 2024.
• The company surpassed 1.5 million lifetime members.
• For Q4 2025, revenue is expected to be between $155 million and $157 million, reflecting 33% year-over-year growth at the midpoint.
• Q4 2025 non-GAAP income from operations is projected to be between $34 million and $36 million, representing 63% year-over-year growth and a 22% non-GAAP operating margin at the midpoint.
• Full-year 2025 revenue guidance was increased to between $572 million and $574 million, reflecting 47% year-over-year growth at the midpoint.
• Full-year 2025 non-GAAP income from operations guidance was increased to between $106 million and $108 million, reflecting a 19% non-GAAP operating margin at the midpoint.

Sentiment

Score: 9

Explanation: The company reported exceptionally strong financial results, including significant revenue growth, a positive shift in non-GAAP operating income, and record free cash flow. The increased full-year guidance further reinforces a very positive outlook and strong operational momentum.

Positives

• Revenue increased 53% year-over-year to $154.2 million, demonstrating strong top-line growth.
• Achieved record free cash flow of $81.3 million, significantly up from $27.5 million in the prior year period.
• Non-GAAP income from operations turned positive at $30.4 million, a substantial improvement from a $3.7 million loss year-over-year.
• GAAP and non-GAAP gross margins improved to 82% and 83% respectively.
• Net cash provided by operating activities increased significantly to $82.4 million.
• Maintained a strong cash position with $496.9 million in cash, cash equivalents, marketable securities, and restricted cash.
• LTM calculated billings grew 50% to $624.2 million, indicating robust sales and future revenue potential.
• Client base expanded by 25% to 2,560 clients, showing strong market penetration.
• Surpassed 1.5 million lifetime members, highlighting growing user adoption and impact.
• Increased full-year 2025 revenue and non-GAAP income from operations guidance, signaling confidence in continued performance.

Negatives

• GAAP loss from operations increased to $6.1 million in Q3 2025 from $3.9 million in Q3 2024.
• GAAP net loss for Q3 2025 was $1.844 million, compared to a net income of $341 thousand in Q3 2024.
• The nine months ended September 30, 2025, show a significant GAAP net loss of $560.356 million, primarily driven by stock-based compensation expense.

Risks

• Actual results in future periods are subject to risks and uncertainties that could cause actual results to differ materially from those projected.
• Risks are more fully described in SEC filings, including the Quarterly Report on Form 10-Q for the quarter ended June 30, 2025, and the upcoming 10-Q for September 30, 2025.
• The company does not provide GAAP income (loss) from operations guidance due to the uncertainty and potential variability of stock-based compensation expense, employer payroll tax expense related to stock-based compensation, amortization of intangible assets, and other adjustments, which could significantly impact future GAAP income (loss) from operations.

Future Outlook

Hinge Health expects Q4 2025 revenue to be between $155 million and $157 million, reflecting 33% year-over-year growth at the midpoint, and non-GAAP income from operations between $34 million and $36 million, representing 63% year-over-year growth and a 22% non-GAAP operating margin at the midpoint. For the full fiscal year 2025, the company increased its revenue guidance to $572 million to $574 million (47% YOY growth at midpoint) and non-GAAP income from operations guidance to $106 million to $108 million (19% non-GAAP operating margin).

Management Comments

• "With healthcare costs rising dramatically, our mission to automate care delivery has never been more urgent." Daniel Perez, Co-Founder and CEO.
• "This quarter we surpassed 1.5 million lifetime members, delivered year-over-year revenue growth of 53%, and generated record free cash flow." Daniel Perez, Co-Founder and CEO.
• "Our AI-powered platform is transforming care at scale, increasing engagement for our members and reducing healthcare costs for our clients." Daniel Perez, Co-Founder and CEO.

Industry Context

Hinge Health operates in the rapidly expanding digital health and virtual care sector, specifically addressing musculoskeletal conditions. The company's AI-powered platform and focus on automating care delivery are well-aligned with the industry's broader trends towards cost reduction and technology-enabled healthcare solutions. The reported growth in clients and members indicates strong adoption of its virtual MSK solutions, positioning it favorably within a competitive and evolving market driven by increasing healthcare costs and demand for accessible, effective care.

Stakeholder Impact

• Shareholders: Likely positive impact due to strong financial performance, increased guidance, and record free cash flow, potentially leading to increased share value.
• Customers (Clients): Continued benefit from the company's AI-powered platform, which aims to reduce healthcare costs and improve care delivery.
• Members: Improved outcomes and experiences through personalized, evidence-based care for musculoskeletal conditions.
• Employees: Positive impact from a growing and financially strong company, although past restructuring efforts were noted in non-GAAP adjustments.

Next Steps

• Host a conference call and webcast for investors on November 4, 2025, at 1:30 p.m. Pacific Time (4:30 p.m. Eastern Time) to discuss financial results, business highlights, and financial outlook.
• File the Quarterly Report on Form 10-Q for the quarter ended September 30, 2025, with the SEC.
• Continue to monitor the investor relations website (ir.hingehealth.com) for material non-public information, upcoming investor conferences, and Regulation FD compliance.

Key Dates

Recommendation

Hinge Health demonstrated exceptional growth in revenue, a significant turnaround in non-GAAP operating profitability, and generated record free cash flow. The increased full-year guidance further reinforces a positive outlook. These strong operational and financial metrics, coupled with expanding client and member bases in a high-growth industry, suggest a compelling investment opportunity for seasoned investors.

Keywords

Digital health, Musculoskeletal care, AI-powered platform, Healthcare technology, Virtual care, Hinge Health, HNGE, Q3 2025 earnings, Financial results, Revenue growth, Free cash flow, Non-GAAP, SEC filing